Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias

E. N. Popova, E. A. Kogan, A. B. Ponomarev, I. A. Popova, V. I. Osipenko (Moscow, Russian Federation)

Source: Annual Congress 2006 - Hypoxic and inflammatory insults to the pulmonary circulation.
Session: Hypoxic and inflammatory insults to the pulmonary circulation.
Session type: Thematic Poster Session
Number: 3826
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. N. Popova, E. A. Kogan, A. B. Ponomarev, I. A. Popova, V. I. Osipenko (Moscow, Russian Federation). Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias. Eur Respir J 2006; 28: Suppl. 50, 3826

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP)
Source: Eur Respir J 2005; 26: Suppl. 49, 540s
Year: 2005

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2015; 24: 392-399
Year: 2015



Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017




Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009

Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020

Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005

Circulating angiopoietins in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Platelet aggregability at night in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 98s
Year: 2002

Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001

Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

D-dimers in patients with chronic obstructive pulmonary disease with or without secondary secondary erythrocytosis
Source: Eur Respir J 2004; 24: Suppl. 48, 14s
Year: 2004

Platelet activity in patients with COPD and concomitant arterial hypertension
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017
Year: 2018



The relationships between PAC-1, CD62P and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017